Skip to main content
Move the World.
Precision Medicine Cured  an “Untreatable” Stage IV Breast Cancer
Judy Perkins, cancer survivor, is back to kayaking again. Credit: Courtesy of Judy Perkins

Two years ago, Judy Perkins had late-stage breast cancer, which had metastasized and spread tumors throughout her body. Doctors at the NIH called it untreatable, and one scientist described it as "basically a death sentence."

But oncologists built her a customized treatment, using her own immune cells, to target the cancer. The treatment eradicated the tumors all over her body, leaving her completely cancer free. According to the study published in Nature Medicine , she's been in "complete durable regression" for almost two years. It's the first time that a metastatic breast cancer has been stopped using this kind of immunotherapy, and it offers hope that other common cancers could be treated using this "precision medicine" model.

Hope in a Hopeless Place

After several rounds of chemo failed to stop her cancer from spreading, Perkins told journalists, "I had given up fighting" and was "planning on dying." Tumors pressed on her nerves and made it excruciating to move, and her condition continued to deteriorate rapidly. The prognosis for metastatic stage IV breast cancer is grim: the five-year survival rate is 22%. Her doctors gave her only "two to three months."

That situation made her a candidate for an experimental trial focusing on just such untreatable cancers, and she was selected for a pilot study at the National Cancer Institute, testing a radical and intensive new treatment.

The Treatment

Scientists biopsied her tumors and painstakingly analyzed the DNA of her cancer cells' DNA to identify the specific mutations that were causing her disease. They zeroed in on a few mutated genes that were found in all of her tumors, which created abnormal proteins. Her doctors then combed the tumors looking for lymphocyte T cells (the Soldiers of the Immune System™) that had invaded the tumors and were fighting a losing battle to destroy them.

They extracted and cultured these T cells, growing billions of them in the lab to find the specific type that would best target the cancerous mutations they had found. When they found the right cells, they grew 80 billion of them* and then injected them into her body. Doctors also gave her a drug that marginally improves the immune system's ability to break down her cancer cells' defenses. Then they waited.

The results were incredible. The customized infusion of T cells rapidly began dissolving the tumors. In six months, her tennis ball-sized tumors had halved in size. In ten months, scans showed her completely cancer-free. Two years later, the cancer is still gone. "After the treatment dissolved most of my tumors," Perkins told the Guardian, "I was able to go for a 40-mile hike." From trying not to move to an ultramarathon-length hike (still with only "mostly dissolved" tumors!) is astonishing.

After the treatment dissolved most of mytumors, I was able to go for a 40-milehike.

Judy Perkins

The Upshot

We can't say just how good this therapy will be for other patients yet, or how many more women could be saved by it. Similar customized infusions failed to work for two other women in the pilot study, and that puts a damper on any wild ideas about there being a silver bullet "for" breast cancer, in general. But it's still a remarkable achievement, because while this sort of treatment has been done before with other cancers, it hasn't worked well with prostate or breast cancers, because they tend to have few identifiable mutations that could guide the T cells to target them.

The larger goal for precision medicine like this is to find and hack the features of disease that are unique to each person, helping the patients who fall through the cracks of medicine designed to work only on the largest number of people.

* If that sounds like a lot, that's because it really is: a healthy adult has about 400 billion total T cells in their body at any given time, and they are busy doing lots of different things, while these 80 billion were selected to focus on just one particular enemy.

Up Next

Public Health
Gates Foundation Funds At-Home Coronavirus Testing Project
coronavirus testing
Public Health
Gates Foundation Funds At-Home Coronavirus Testing Project
The Gates Foundation is funding an at-home coronavirus testing project in Seattle, with the goal of testing thousands of people for COVID-19 daily.

The Gates Foundation is funding an at-home coronavirus testing project in Seattle, with the goal of testing thousands of people for COVID-19 daily.

Seachange
The Fight to End Illegal Logging
illegal logging
Seachange
The Fight to End Illegal Logging
Citizen scientists are collecting tree samples to build a genetic database that will help identify the origins of stolen lumber and stop illegal logging.

Citizen scientists are collecting tree samples to build a genetic database that will help identify the origins of stolen lumber and stop illegal logging.

Dispatches
How Redesigning Labs Can Demystify Genetic Science
How Redesigning Labs Can Demystify Genetic Science
Dispatches
How Redesigning Labs Can Demystify Genetic Science
"Scientists work in high-security buildings that are banned to the public and then wonder why they are misunderstood."
By Brook Muller

"Scientists work in high-security buildings that are banned to the public and then wonder why they are misunderstood."

Dispatches
Paige and the Virus Hunter
Paige and the Virus Hunter
Dispatches
Paige and the Virus Hunter
Drugs couldn’t stop her infection — so she asked Ben Chan to get her a virus, instead.
By Kaitlin Ugolik

Drugs couldn’t stop her infection — so she asked Ben Chan to get her a virus, instead.

Dispatches
CRISPR Edits Out Autistic Traits in Mice
CRISPR Edits Out Autistic Traits in Mice
Dispatches
CRISPR Edits Out Autistic Traits in Mice
The technique could also open up treatments for Huntington's, schizophrenia, and epilepsy.

The technique could also open up treatments for Huntington's, schizophrenia, and epilepsy.

Dispatches
The Cause (and Possible Cure) for Most Infertility
The Cause (and Possible Cure) for Most Infertility
Dispatches
The Cause (and Possible Cure) for Most Infertility
Fertility medicine may be on the edge of a breakthrough.

Fertility medicine may be on the edge of a breakthrough.

The New Space Race
A Delivery Service for the Moon
A Delivery Service for the Moon
Watch Now
The New Space Race
A Delivery Service for the Moon
This startup wants to offer the world insanely accurate shipping to the moon.
Watch Now

Landing on the moon has always been an inaccurate pursuit. But Astrobotic has fixed that problem. The company’s unique GPS system allows it to land spacecraft within meters—rather than kilometers—of the intended target. And now they’re using the tech to offer the world’s first delivery service to the moon.

The New Space Race
New Space Race Trailer
New Space Race Trailer
Watch Now
The New Space Race
New Space Race Trailer
Meet the next generation of explorers taking us higher and farther than ever before.
Watch Now

In July of 2011, the U.S. suspended its decades-long Space Shuttle program, officially ending an era of space exploration that began over half a century ago. Some have mourned its passing as a sign of the times – as evidence that we could no longer dare to dream. But unbeknownst to many, a new era of private space exploration has already begun... and it’s firing on all cylinders. The New Space Race is the story of a...

Superhuman
Meet the Wounded Veteran Using Bionics to Take Back His Independence
Jerral Hancock Wounded Veteran with Bionics
Superhuman
Meet the Wounded Veteran Using Bionics to Take Back His Independence
Jerral lost his left arm in Iraq. Now he's working with a team from Johns Hopkins to test a prosthetic arm that...
By Mike Riggs

Jerral lost his left arm in Iraq. Now he's working with a team from Johns Hopkins to test a prosthetic arm that works by reading signals in his skin.